LPCUF (Lee's Pharmaceutical Holdings) Inventories, Finished Goods: $17.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LPCUF Lee's Pharmaceutical Holdings Ltd LPCUF
75 GF Score
Price $0.19
GF Value $0.28
! 5 Warning Signs
View Full Analysis

What is Lee's Pharmaceutical Holdings Inventories, Finished Goods?

Lee's Pharmaceutical Holdings LPCUF 75 Inventories, Finished Goods is $17.0 Mil as of Dec. 2025. GuruFocus rates LPCUF with a GF Score™ of 75/100 and a GF Value™ of $0.28. The stock has 5 warning signs investors should review.

Lee's Pharmaceutical Holdings's quarterly finished goods declined from Dec. 2024 ($15.5 Mil) to Jun. 2025 ($0.0 Mil) but then increased from Jun. 2025 ($0.0 Mil) to Dec. 2025 ($17.0 Mil).

Lee's Pharmaceutical Holdings's annual finished goods increased from Dec. 2023 ($14.4 Mil) to Dec. 2024 ($15.5 Mil) and increased from Dec. 2024 ($15.5 Mil) to Dec. 2025 ($17.0 Mil).

Lee's Pharmaceutical Holdings Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Lee's Pharmaceutical Holdings's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lee's Pharmaceutical Holdings Inventories, Finished Goods Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.66 15.85 14.44 15.45 17.00

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.44 0.00 15.45 0.00 17.00
LPCUF
75GF Score
Lee's Pharmaceutical Holdings Ltd LPCUF
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lee's Pharmaceutical Holdings Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $17.0 Mil mean?
Lee's Pharmaceutical Holdings (LPCUF) has a Inventories, Finished Goods of $17.0 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on Lee's Pharmaceutical Holdings and its competitors.
Is Lee's Pharmaceutical Holdings' Inventories, Finished Goods too high?
Lee's Pharmaceutical Holdings' current Inventories, Finished Goods is $17.0 Mil. Overall, Lee's Pharmaceutical Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Lee's Pharmaceutical Holdings' Inventories, Finished Goods compare to ZTS?
Lee's Pharmaceutical Holdings' Inventories, Finished Goods of $17.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Lee's Pharmaceutical Holdings and its competitors. Lee's Pharmaceutical Holdings's current Inventories, Finished Goods is $17.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lee's Pharmaceutical Holdings stock overvalued right now?
Lee's Pharmaceutical Holdings (LPCUF) has a current Inventories, Finished Goods of $17.0 Mil. The stock's GF Value™ is $0.28, compared to a current price of $0.19 — trading 32% below its estimated fair value. The current Inventories, Finished Goods is $17.0 Mil. Lee's Pharmaceutical Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Lee's Pharmaceutical Holdings (LPCUF), the current Inventories, Finished Goods is $17.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lee's Pharmaceutical Holdings (LPCUF) Overvalued in 2026?

Based on GuruFocus' analysis, Lee's Pharmaceutical Holdings stock appears to be undervalued. The current stock price of $0.19 is trading 32% below its estimated GF Value™ of $0.28.

Key valuation signals for LPCUF:

  • Inventories, Finished Goods: $17.0 Mil
  • GF Value™: $0.28 vs. price of $0.19 (32% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the LPCUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lee's Pharmaceutical Holdings Business Description

Other Exchanges 00950:Hong Kong
Address Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
75GF Score

Get the complete analysis for LPCUF

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$0.28
GF Value